Abstract:Background: Acinetobacter baumannii (A. baumannii) is an opportunistic pathogen associated with serious hospital acquired infections. It is resistant to multiple antibiotics. The therapy for infections due to this bacterium is a combination of aminoglycosides with carbapenem antibiotics. There are recent reports of the prevalence of ami-noglycoside resistance among A. baumannii. The aim of the present study was to determine the prevalence of phosphotransferases APH (3')-Via (aphA6), acetyltransferases AAC (3)-Ia (aacC1), nucleotidyl transferases ANT (2'')-Ia (aadB), and ANT (3") -Ia (aadA1) genes among clinical isolates of A. baumannii and its relation to resis-tance to amikacin and gentamicin. Methods: The study included all clinical samples from intensive care units (ICUs) patients with suspected hospital acquired infections. Positive cultures were identified by Gram stain and complete biochemical identifications. An-tibiotic susceptibility was carried out by disc diffusion method. Minimum inhibitory concentration determination (MIC) to amikacin and gentamicin was performed by microdilution method. Polymerase chain reaction (PCR) was performed for detection of aadB, aadA1, aphA6, aadC1 genes. Results: The study included 1,200 bacterial isolates from patients admitted to ICUs during the period of the study. A. baumannii represented 100 isolates from Gram negative bacilli. The study of MIC of A. baumannii to amikacin and gentamicin revealed that 50 (50%) of the isolates had resistance by MIC study with 36 (72%) of those having high level aminoglycoside resistance (HLAR) and 14 (28%) had non-high-level aminoglycoside resistance. The most common prevalent resistant genes among A. baumannii resistance to aminoglycosides was aadB (42%), fol-lowed by aphA6 (26%). Less prevalent genes were aadA1 (18%) and aacC1 (12%). There were 24 isolates with negative PCR for the studied genes. In a comparison between the prevalence of resistant genes among A. baumannii with HLAR and non HLAR, there was a non-significant increase of aphA6 (30.6%) and aadB (44.4%) in HLAR isolates compared to non HLAR (14.3%, 35.7%, respectively; p = 0.2), with a significant increase in aacC1 28.6% in HLAR compared to 5.6% in non HLAR (p = 0.02). Conclusions: Half of the clinical isolates of A. baumannii have resistance to the aminoglycosides amikacin and gen-tamicin. Most isolates have a high resistance level to aminoglycosides. The isolates have different types of amino-glycoside modifying genes. Further studies are required to detect other genes associated with resistance to amino-glycosides.

The Resistance and Aminoglycoside-Modifying Enzyme Genotypes of High-Level Amino-Glycoside Resistant Enterococcus

Genotypes of Aminoglycoside-Modifying Enzyme and Clinical Study of High-Level Gentamycin Resistant Enterococcus

Genotypic Diversity And Epidemiology Of High-Level Gentamicin Resistant Enterococcus In A Chinese Hospital

Evaluation of Aminoglycoside Resistance Phenotypes and Genotyping of Acetyltransferase in Escherichia Coli

Emergence of novel variants of DNA gyrase subunit A gyrA gene in drug-resistant Enterobacter aerogenes

Identification on a New Subtype Gene of Aminoglycoside Modifying Enzyme in Multi-drug Resistant Acinetobacter baumannii

Surveillance of antibiotic resistance in clinical isolates from First Affiliated Hospital of Zhejiang University Medical College in 2009

Aminoglycoside-resistant genes in Klebsiella pneumoniae

Genotypes of Aminoglycosides Modifying Enzymes in Imipenem-Resistant Pseudomonas Aeruginosa

The study of aminoglycoside-modifying enzymes gene in imipenem-resistant pseudomonas aeruginosa

Prevalence of 16S Rrna Methylase Conferring High-Level Aminoglycoside Resistance in Escherichia Coli in China

The Resistance Genes of Extended- Spectrum Β- Lactamases in Enterobacter Cloacae

Drug-resistance Mechanisms and Prevalence of Enterobacter Cloacae Resistant to Multi-Antibiotics

Epidemiological Characteristics and Genetic Structure of Linezolid-Resistant Enterococcus Faecalis

High-level aminoglycoside resistance and distribution of aminoglycoside resistance genes among Enterococcus spp. clinical isolates in Tehran, Iran

Detection of Transposons Conferring High Level Gentamicin Resistance in Enterococcus

Analysis of High-Level Gentamicin Resistant Genes in Enterococcus Faecium

The Status of Drug Resistance and Ampc Gene Expression in Enterobacter Cloacae

Aminoglycoside Resistance Genes in Acinetobacter baumannii Clinical Isolates

The major aminoglycoside-modifying enzyme AAC(3)-II found in Escherichia coli determines a significant disparity in its resistance to gentamicin and amikacin in China.

Coexistence of Arma and Genes Encoding Aminoglycoside-Modifying Enzymes in Acinetobacter Baumannii